5KAO
Crystal structure of wild type HIV-1 protease in complex with GRL-10413
Summary for 5KAO
Entry DOI | 10.2210/pdb5kao/pdb |
Related | 4HLA |
Descriptor | protease, [(3~{a}~{S},4~{R},6~{a}~{R})-2,3,3~{a},4,5,6~{a}-hexahydrofuro[2,3-b]furan-4-yl] ~{N}-[(2~{S},3~{R})-1-(3-chloranyl-4-methoxy-phenyl)-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-butan-2-yl]carbamate (3 entities in total) |
Functional Keywords | grl-10413, hiv-1 protease, protease-inhibitor, darunavir, 2-chloroanisole, nonpeptidic, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Human immunodeficiency virus 1 |
Total number of polymer chains | 2 |
Total formula weight | 22078.34 |
Authors | Yedidi, R.S.,Delino, N.S.,Das, D.,Kaufman, J.D.,Wingfield, P.T.,Ghosh, A.K.,Mitsuya, H. (deposition date: 2016-06-01, release date: 2016-08-31, Last modification date: 2023-09-27) |
Primary citation | Amano, M.,Salcedo-Gomez, P.M.,Zhao, R.,Yedidi, R.S.,Das, D.,Bulut, H.,Delino, N.S.,Sheri, V.R.,Ghosh, A.K.,Mitsuya, H. A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413. Antimicrob.Agents Chemother., 60:7046-7059, 2016 Cited by PubMed: 27620483DOI: 10.1128/AAC.01428-16 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.8 Å) |
Structure validation
Download full validation report